%0 Journal Article
%T Myelosuppression Effect Of Trimethoprim-Sulfamethoxazole Prophylaxis In Innate Immune Defect Patients: Retrospective Comparative Study
%A Mehdi Adeli
%A Reem Elajez
%J Journal of Allergy and Clinical Immunology
%D 2018
%R 10.1016/j.jaci.2017.12.078
%X To indicate and report the frequency of myelosuppression effect seen with prophylactic
dose of Trimethoprim-Sulfamethoxazole (TMP-SMX) in two groups: innate immune defect
patients without bone marrow suppression, and immune competent patients for urinary
tract infection (UTI)
%U https://www.jacionline.org/article/S0091-6749(17)31978-4/abstract